Australia · Delayed Price · Currency is AUD Algorae Pharmaceuticals Statistics
Total Valuation
ASX:1AI has a market cap or net worth of AUD 13.50 million. The enterprise value is 11.18 million.
| Market Cap | 13.50M |
| Enterprise Value | 11.18M |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:1AI has 1.69 billion shares outstanding. The number of shares has decreased by -0.38% in one year.
| Current Share Class | 1.69B |
| Shares Outstanding | 1.69B |
| Shares Change (YoY) | -0.38% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 17.67% |
| Owned by Institutions (%) | 2.43% |
| Float | 1.05B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 95.70 |
| PB Ratio | 6.06 |
| P/TBV Ratio | 6.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.92 |
| EV / Sales | 79.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.13
| Current Ratio | 14.13 |
| Quick Ratio | 13.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -308.56 |
Financial Efficiency
Return on equity (ROE) is -30.63% and return on invested capital (ROIC) is -22.07%.
| Return on Equity (ROE) | -30.63% |
| Return on Assets (ROA) | -20.69% |
| Return on Invested Capital (ROIC) | -22.07% |
| Return on Capital Employed (ROCE) | -41.53% |
| Revenue Per Employee | 2,939 |
| Profits Per Employee | -16,728 |
| Employee Count | 48 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -737,178 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.50% in the last 52 weeks. The beta is 0.13, so ASX:1AI's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +12.50% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 56.60 |
| Average Volume (20 Days) | 3,601,839 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:1AI had revenue of AUD 141,050 and -802,958 in losses. Loss per share was -0.00.
| Revenue | 141,050 |
| Gross Profit | 141,050 |
| Operating Income | -925,668 |
| Pretax Income | -1.54M |
| Net Income | -802,958 |
| EBITDA | n/a |
| EBIT | -925,668 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2.32 million in cash and n/a in debt, giving a net cash position of 2.32 million or 0.00 per share.
| Cash & Cash Equivalents | 2.32M |
| Total Debt | n/a |
| Net Cash | 2.32M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.23M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.23M |
Cash Flow
| Operating Cash Flow | -785,250 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -656.27% |
| Pretax Margin | -1,091.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:1AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.95% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |